Icon Bioscience Verisome Technology
IBI’s Verisome® drug delivery technology is a highly advanced, yet elegant formulation for controlling the release of intraocular therapeutic agents in the eye for extended periods of time. The technology’s exceptional versatility can support products individually formulated to meet the particular clinical requirements of a given active agent targeting a specific ophthalmic disease. Our product development portfolio currently consists of broad range of drug candidates, all addressing significant unmet medical needs in large ophthalmic pharmaceutical spaces. To date, several hundreds of patients have been administered products based on the Verisome® drug delivery technology.